chemical

AM 1172

3381

10 mg

193 USD

3381

3381/10

AM 1172

Anandamide uptake inhibitor; also FAAH inhibitor and CB receptor partial agonist

Cannabinoid Transporter Inhibitors

Small Molecules

10 mg

98%

409.6

?utm_source=distributor&utm_medium=referral&utm_campaign=product&utm_term=smallmolecules

Metabolically stable anandamide uptake inhibitor (IC50 = 2.1 - 2.5 M) and fatty acid amide hydrolase (FAAH) inhibitor (Ki = 3.18 M). Inhibits N -arachidonylethanolamine (AEA) accumulation (IC50 = 24 M) and hydrolysis (Ki = 3 M), and inhibits N -palmitoylethanolamine (PEA) hydrolysis (IC50 = 36 M) in cerebellar granule neurons. Also acts as a non-selective cannabinoid receptor partial agonist (EC50 values are 189 and 271 nM at CB2 and CB1 receptors respectively). FABP inhibitor.

3381

Anandamide uptake inhibitors inhibits AMT FAAH inhibitor CB receptors partial agonists cannabinoid fatty acid amide hydrolase neurotransmitter transporters AM1172 cb2r cb1r FABP FABPs fatty acid binding protein Cannabinoid Transporters Non-selective Cannabinoids Fatty Acid Amide Hydrolase (FAAH) Other Cannabinoids Fatty Acid Binding Proteins 3381,

Anandamide uptake inhibitor; also FAAH inhibitor and CB receptor partial agonist

N-(5Z,8Z,11Z,14Z)-5,8,11,14-eicosatetraen-1-yl-4-hydroxybenzamide

C 27 H 39 NO 2

C27H39NO2

251908-92-6

189

193 USD

Store at -20°C